Literature DB >> 10694249

Modulation by bicuculline and penicillin of the block by t-butyl-bicyclo-phosphorothionate (TBPS) of GABA(A)-receptor mediated Cl(-)-current responses in rat striatal neurones.

J C Behrends1.   

Abstract

1. T-butyl-bicyclo-phosphorothionate (TBPS) is a prototypical representative of the cage-convulsants which act through a use-dependent block of the GABA(A)-receptor-ionophore complex. Using current recordings from cultured neurones of rat striatum the manner was investigated in which two antagonists, bicuculline and penicillin, presumably acting at the agonist binding site and in the ionic channel, respectively, modify the rate of block by TBPS. 2. Penicillin (5 or 10 mM) did not slow the rate of block by TBPS, but produced a significant enhancement of block rate, which, however, was inversely related to the degree of antagonism by penicillin of the GABA-induced current. 3. Bicuculline (10 microM) reduced the rate of block by TBPS. However, this effect was 3 fold weaker than its GABA-antagonistic action. The slowing of block rate and the current antagonism exhibited a biphasic, positive-negative relationship. Co-application of bicuculline (100 microM) in a concentration that produced nearly complete antagonism and TBPS (10 microM) resulted in a marked ( approximately 40%) reduction of subsequent GABA response amplitudes compatible with a direct, bicuculline-induced conformational change in the receptor required for the binding of and block by TBPS. 4. The lack of protection afforded by the channel blocker penicillin as well as the lack of correlation between bicuculline antagonism of the Cl(-)-current and its efficiency in protecting against TBPS block is evidence against an open channel blocking mechanism for TBPS. TBPS does, therefore, not appear to gain access to its binding site via the open pore but through alternative routes regulated from the agonist binding site.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694249      PMCID: PMC1571847          DOI: 10.1038/sj.bjp.0703063

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  High probability opening of NMDA receptor channels by L-glutamate.

Authors:  C E Jahr
Journal:  Science       Date:  1992-01-24       Impact factor: 47.728

2.  Studies on the mechanism of action of picrotoxinin and other convulsants at the crustacean muscle GABA receptor.

Authors:  T G Smart; A Constanti
Journal:  Proc R Soc Lond B Biol Sci       Date:  1986-03-22

3.  Heterogeneous release properties of visualized individual hippocampal synapses.

Authors:  V N Murthy; T J Sejnowski; C F Stevens
Journal:  Neuron       Date:  1997-04       Impact factor: 17.173

4.  [35S]t-butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to gamma-aminobutyric acid-A and ion recognition sites.

Authors:  R F Squires; J E Casida; M Richardson; E Saederup
Journal:  Mol Pharmacol       Date:  1983-03       Impact factor: 4.436

5.  The effect of procaine on the action of acetylcholine at the neuromuscular junction.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1975-07       Impact factor: 5.182

6.  Convulsant-induced depression of amino acid responses in cultured mouse spinal neurones studied under voltage clamp.

Authors:  J L Barker; R N McBurney; D A Mathers
Journal:  Br J Pharmacol       Date:  1983-12       Impact factor: 8.739

7.  Bicuculline-produced regional differences in the modulation of 35S-TBPS binding by GABA, pentobarbital and diazepam in mouse cerebellum and cortex.

Authors:  S Liljequist; B Tabakoff
Journal:  J Pharmacol Exp Ther       Date:  1993-02       Impact factor: 4.030

Review 8.  Steroid modulation of the GABA/benzodiazepine receptor-linked chloride ionophore.

Authors:  K W Gee
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

9.  GABA receptors induced in Xenopus oocytes by chick brain mRNA: evaluation of TBPS as a use-dependent channel-blocker.

Authors:  C Van Renterghem; G Bilbe; S Moss; T G Smart; A Constanti; D A Brown; E A Barnard
Journal:  Brain Res       Date:  1987-04       Impact factor: 3.252

10.  A study of the action of picrotoxin on the inhibitory neuromuscular junction of the crayfish.

Authors:  A Takeuchi; N Takeuchi
Journal:  J Physiol       Date:  1969-11       Impact factor: 5.182

View more
  6 in total

1.  Replacement of asparagine with arginine at the extracellular end of the second transmembrane (M2) region of insect GABA receptors increases sensitivity to penicillin G.

Authors:  Alastair M Hosie; Steven D Buckingham; Alain Hamon; David B Sattelle
Journal:  Invert Neurosci       Date:  2006-04-29

Review 2.  Neuropsychiatric Effects of Antimicrobial Agents.

Authors:  Nicholas Zareifopoulos; George Panayiotakopoulos
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

3.  Influences on blockade by t-butylbicyclo-phosphoro-thionate of GABA(A) receptor spontaneous gating, agonist activation and desensitization.

Authors:  Nidaa A Othman; Michael Gallacher; Tarek Z Deeb; Daniel T Baptista-Hon; David C Perry; Tim G Hales
Journal:  J Physiol       Date:  2011-11-14       Impact factor: 5.182

4.  Mapping convulsants' binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites.

Authors:  A V Kalueff
Journal:  Neurochem Int       Date:  2006-09-07       Impact factor: 3.921

5.  A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype.

Authors:  Kirk Nylen; Jose Luis Perez Velazquez; Sergei S Likhodii; Miguel A Cortez; Lily Shen; Yevgen Leshchenko; Khosrow Adeli; K Michael Gibson; W M Burnham; O Carter Snead
Journal:  Exp Neurol       Date:  2007-11-29       Impact factor: 5.330

6.  Context-dependent modulation of alphabetagamma and alphabetadelta GABA A receptors by penicillin: implications for phasic and tonic inhibition.

Authors:  Hua-Jun Feng; Emmanuel J Botzolakis; Robert L Macdonald
Journal:  Neuropharmacology       Date:  2008-08-19       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.